<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about LXRX</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Tue, 18 Jun 2013 21:39:44 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=LXRX" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/premarket-earnings-report-for-may-10-2013-siro-wcrx-erf-drh-evep-becn-mt-awr-lxrx-hl-trlg-stb-cm245037">
      <guid isPermaLink="false">245037</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eic1jFDBiS8/premarket-earnings-report-for-may-10-2013-siro-wcrx-erf-drh-evep-becn-mt-awr-lxrx-hl-trlg-stb-cm245037</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>Pre-Market Earnings Report for May 10, 2013 :  SIRO, WCRX, ERF, DRH, EVEP, BECN, MT, AWR, LXRX, HL, TRLG, STB</title>
      <description>The following companies are expected to report earnings prior to market open on 05/10/2013. Visit our  Earnings Calendar  for a full list of expected earnings releases.   Sirona Dental Systems,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/eic1jFDBiS8" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 10 May 2013 00:00:03 Z</pubDate>
      <a10:updated>2013-05-09T20:22:12Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AWR</nasdaq:tickers>
      <nasdaq:tickers>BECN</nasdaq:tickers>
      <nasdaq:tickers>DRH</nasdaq:tickers>
      <nasdaq:tickers>ERF</nasdaq:tickers>
      <nasdaq:tickers>EVEP</nasdaq:tickers>
      <nasdaq:tickers>HL</nasdaq:tickers>
      <nasdaq:tickers>LXRX</nasdaq:tickers>
      <nasdaq:tickers>MT</nasdaq:tickers>
      <nasdaq:tickers>SIRO</nasdaq:tickers>
      <nasdaq:tickers>STB</nasdaq:tickers>
      <nasdaq:tickers>TRLG</nasdaq:tickers>
      <nasdaq:tickers>WCRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-earnings-report-for-may-10-2013-siro-wcrx-erf-drh-evep-becn-mt-awr-lxrx-hl-trlg-stb-cm245037</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/market-wrap-for-monday-april-29-stocks-start-week-with-a-rally-cm241763">
      <guid isPermaLink="false">241763</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/usQ_9hv2Rhg/market-wrap-for-monday-april-29-stocks-start-week-with-a-rally-cm241763</link>
      <category>Investing</category>
      <category>Bonds</category>
      <category>Commodities</category>
      <category>Futures</category>
      <category>International</category>
      <title>Market Wrap for Monday, April 29: Stocks Start Week With a Rally</title>
      <description>The S&amp;amp;P 500 traded into record high territory on Monday as the markets started the week off on a strong note.  A rally in U.S. stocks was sparked in part by better than expected&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/usQ_9hv2Rhg" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 30 Apr 2013 00:12:13 Z</pubDate>
      <a10:updated>2013-05-01T19:43:32Z</a10:updated>
      <author>Scott Rubin</author>
      <nasdaq:tickers>CPTS</nasdaq:tickers>
      <nasdaq:tickers>LXRX</nasdaq:tickers>
      <nasdaq:tickers>SPY</nasdaq:tickers>
      <nasdaq:tickers>TLT</nasdaq:tickers>
      <nasdaq:tickers>UUP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/market-wrap-for-monday-april-29-stocks-start-week-with-a-rally-cm241763</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/stocks-surge-as-fiscal-cliff-deal-appears-close-cm203199">
      <guid isPermaLink="false">203199</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z5Y134SOcy4/stocks-surge-as-fiscal-cliff-deal-appears-close-cm203199</link>
      <category>Investing</category>
      <category>Bonds</category>
      <category>Commodities</category>
      <category>Economy</category>
      <category>Futures</category>
      <title>Stocks Surge as Fiscal Cliff Deal Appears Close</title>
      <description>The U.S. stock market jumped on Monday as Congressional lawmakers suggested that a deal to avert the looming "fiscal cliff" appears to be near at hand. Throughout the day, the market&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Z5Y134SOcy4" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 01 Jan 2013 02:46:00 Z</pubDate>
      <a10:updated>2013-01-01T05:04:26Z</a10:updated>
      <author>Scott Rubin</author>
      <nasdaq:tickers>AAPL</nasdaq:tickers>
      <nasdaq:tickers>LXRX</nasdaq:tickers>
      <nasdaq:tickers>ORCL</nasdaq:tickers>
      <nasdaq:tickers>SPY</nasdaq:tickers>
      <nasdaq:tickers>TLT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/stocks-surge-as-fiscal-cliff-deal-appears-close-cm203199</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/orphan-drug-status-for-lexicon-drug-analyst-blog-cm129437">
      <guid isPermaLink="false">129437</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1ZrVT8z6NhM/orphan-drug-status-for-lexicon-drug-analyst-blog-cm129437</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Orphan Drug Status for Lexicon Drug - Analyst Blog</title>
      <description>Lexicon Pharmaceuticals, Inc.   (   LXRX   ) recently announced that its candidate telotristat etiprate (LX1032) has been granted orphan drug status by the US Food and Drug Administration&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/1ZrVT8z6NhM" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 23 Mar 2012 21:15:01 Z</pubDate>
      <a10:updated>2012-03-23T18:24:13Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>LXRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/orphan-drug-status-for-lexicon-drug-analyst-blog-cm129437</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/investing-101-rallying-stocks-under-5-undervalued-to-analyst-estimates-cm86003">
      <guid isPermaLink="false">86003</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OLjek-nTJ1s/investing-101-rallying-stocks-under-5-undervalued-to-analyst-estimates-cm86003</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Investing 101: Rallying Stocks Under $5 Undervalued to Analyst Estimates</title>
      <description>( List compiled by Becca Lipman )  Penny stocks have a solid reputation for being risky investments. However, if the potential rewards excite you, then the list below may provide an interesting&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/OLjek-nTJ1s" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 19 Jul 2011 02:49:51 Z</pubDate>
      <a10:updated>2011-07-19T21:47:46Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>AXAS</nasdaq:tickers>
      <nasdaq:tickers>BPAX</nasdaq:tickers>
      <nasdaq:tickers>CHRS</nasdaq:tickers>
      <nasdaq:tickers>CRIS</nasdaq:tickers>
      <nasdaq:tickers>DENN</nasdaq:tickers>
      <nasdaq:tickers>DVAX</nasdaq:tickers>
      <nasdaq:tickers>GEN</nasdaq:tickers>
      <nasdaq:tickers>HDY</nasdaq:tickers>
      <nasdaq:tickers>IMMU</nasdaq:tickers>
      <nasdaq:tickers>LXRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/investing-101-rallying-stocks-under-5-undervalued-to-analyst-estimates-cm86003</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/8-biotech-penny-stocks-to-buy-now-cm59896">
      <guid isPermaLink="false">59896</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1ps_nQqKUIg/8-biotech-penny-stocks-to-buy-now-cm59896</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>8 Biotech Penny Stocks to Buy Now</title>
      <description>Biotech penny stocks   are some of the most exciting investments. While cheap   penny stock picks   with small market caps can be aggressive buys, they don't always have to be "all or&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/1ps_nQqKUIg" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 01 Mar 2011 16:20:33 Z</pubDate>
      <a10:updated>2011-03-01T17:52:31Z</a10:updated>
      <author>Louis Navellier</author>
      <nasdaq:tickers>LXRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/8-biotech-penny-stocks-to-buy-now-cm59896</feedburner:origLink></item>
  </channel>
</rss>
